Thomas David Hull III Sells 1,368 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 1,368 shares of the business's stock in a transaction on Friday, January 10th. The shares were sold at an average price of $60.08, for a total transaction of $82,189.44. Following the completion of the transaction, the chief executive officer now directly owns 41,129 shares of the company's stock, valued at $2,471,030.32. This trade represents a 3.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Thomas David Hull III also recently made the following trade(s):

• On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $63.01, for a total transaction of $126,020.00.

Kewaunee Scientific Stock Down 4.4 %

NASDAQ:KEQU traded down $2.53 on Monday, hitting $55.20. 15,577 shares of the company's stock were exchanged, compared to its average volume of 30,768. The firm has a 50-day moving average price of $48.37 and a 200-day moving average price of $45.02. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00. Kewaunee Scientific Co. has a 52 week low of $27.00 and a 52 week high of $67.20. The company has a market cap of $158.53 million, a P/E ratio of 8.75 and a beta of 0.72.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of KEQU. JPMorgan Chase & Co. increased its holdings in shares of Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock worth $30,000 after purchasing an additional 900 shares during the period. Barclays PLC bought a new position in shares of Kewaunee Scientific during the third quarter worth approximately $121,000. Heron Bay Capital Management bought a new position in shares of Kewaunee Scientific during the second quarter worth approximately $252,000. State Street Corp bought a new position in shares of Kewaunee Scientific during the third quarter worth approximately $266,000. Finally, Ritholtz Wealth Management increased its holdings in shares of Kewaunee Scientific by 24.6% during the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company's stock worth $363,000 after purchasing an additional 2,156 shares during the period. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Kewaunee Scientific from a "hold" rating to a "buy" rating in a research report on Wednesday, December 18th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.